Showing results (61-70 of 137) with videos related to

Sort By:
Pageof 14
British Journal of Cancer|March 7, 2013
Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancerA Brédart, J L Kop, A Depauw, et al.
Cancer Research|May 1, 1998
Mutations at BRCA1: the medullary breast carcinoma revisitedF Eisinger, J Jacquemier, C Charpin, et al.
Familial Cancer|September 16, 2010
Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanomaB Buecher, M Gauthier-Villars, L Desjardins, et al.
Lancet (London, England)|December 29, 2000
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study GroupS A Narod, J S Brunet, P Ghadirian, et al.
American Journal of Medical Genetics|October 27, 1998
Marker segregation information in breast/ovarian cancer genetic counseling: is it still useful? Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le CancerL Essioux, C Girodet, O Sinilnikova, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|November 19, 2013
Regulatory effects of homoeologous chromosome arms on wheat proteins at two developmental stagesH Thiellement, N Bahrman, C Colas des Francs
Neurogenetics|May 15, 2009
Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical managementM Anheim, M Fleury, B Monga, et al.
Annales D'Endocrinologie|April 6, 1999
[INSERM-FNCLCC collective expert's report. Recommendations for management of women having a genetic risk of developing breast and/or ovarian cancer. National Federation of Centers of the Fight Against Cancer]F Eisinger, N Alby, A Bremond, et al.
Annales De Genetique|April 24, 1999
[INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer]F Eisinger, N Alby, A Bremond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc CommitteeF Eisinger, N Alby, A Bremond, et al.
Pageof 14